Hospira Inc. (NYSE:HSP) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are up 0.78%.
Hospira Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 7.84% to $0.55 in the quarter versus EPS of $0.51 in the year-earlier quarter.
Revenue: Decreased 0.69% to $1.03 billion from the year-earlier quarter.
Actual vs. Wall St. Expectations: Hospira Inc. reported adjusted EPS income of $0.55 per share. By that measure, the company beat the mean analyst estimate of $0.51. It missed the average revenue estimate of $1.03 billion.
Quoting Management: “Today’s announcement is confirmation that Inflectra has met the very rigorous quality, safety and efficacy requirements that have been established by the EMA, and provides the next step toward Inflectra being approved for use in Europe ,” said Dr. Stan Bukofzer , Corporate Vice President and Chief Medical Officer, Hospira.
Key Stats (on next page)…